Expensify, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(unaudited, in thousands, except share data)
| Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||
| Balance at December 31, 2025 | — | $— | 93,060,902 | $9 | $304,953 | $(172,217) | $132,745 |
| Issuance of common stock upon exercise of stock options | — | — | 43,759 | — | 39 | — | 39 |
| Issuance of restricted stock units | — | — | 3,268 | — | 5 | — | 5 |
| Settlement of liability-classified restricted common shares | — | — | 459,586 | — | — | — | — |
| Issuance of common stock under Matching Plan | — | — | 2,682,042 | 1 | 1,827 | — | 1,828 |
| Issuance of common stock in connection with restricted stock units vesting | — | — | 183,186 | — | — | — | — |
| Stock-based compensation | — | — | — | — | 6,248 | — | 6,248 |
| Net loss | — | — | — | — | — | (2,337) | (2,337) |
| Balance at March 31, 2026 | — | $— | 96,432,743 | $10 | $313,072 | $(174,554) | $138,528 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(unaudited, in thousands, except share data)
| Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | |||||||
| Balance at December 31, 2024 | — | $— | 91,376,765 | $9 | $279,062 | $(150,828) | $128,243 |
| Issuance of common stock upon exercise of stock options | — | — | 75,289 | — | 91 | — | 91 |
| Vesting of early exercised stock options | — | — | — | — | 88 | — | 88 |
| Issuance of restricted stock units | — | — | 4,957 | — | 18 | — | 18 |
| Issuance of common stock under Matching Plan | — | — | 729,486 | — | 1,151 | — | 1,151 |
| Issuance of common stock in connection with restricted stock units vesting | — | — | 197,170 | — | — | — | — |
| Stock-based compensation | — | — | — | — | 8,229 | — | 8,229 |
| Net loss | — | — | — | — | — | (3,169) | (3,169) |
| Balance at March 31, 2025 | — | $— | 92,383,667 | $9 | $288,639 | $(153,997) | $134,651 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.